Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
Solving the Puzzle of Cell Culture Optimization
Assembling a Jigsaw Puzzle Is Not Nearly as Tricky as Building a Stable and Productive Bioprocess
For full access to this article login to GEN Select now.
Strategies for Successful Process Scale-Up
Advanced Tools Provide Better Solutions for Critical Aspect of Biologics Development
- Scaling up biologics production from the bench to clinical and commercial scale is a central consideration of process design and development. Issues, challenges, and new technologies in scale-up were all discussed at “BioProcess International Europe” held in Vienna recently. The meeting began with a case study of scale-up in ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.